Immunogenicity and reactogenicity of DTPw-HB/Hib vaccine administered to Colombian infants after a birth dose of hepatitis B vaccine

Expert Review of Vaccines

Volumn 1, Issue 3, 2002, Pages 277-283

  López, Pio ^a   Rubiano, Luisa ^b,c   Del Pilar Rubio, Maria ^d   David, Marie Pierre ^e   Salary, Assad ^e  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b Ctro Materno Inf Los Farallones   (Costa Rica)

^c Office 402   (Colombia)

^d GLAXOSMITHKLINE   (United Kingdom)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Diphtheria; Haemophilus influenzae b combination vaccine; Hepatitis B; Immunogenicity; Infants; Ractogenicity; Tetanus; Whole cell pertussis

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ANOREXIA; ARTICLE; CLINICAL TRIAL; COLOMBIA; DIPHTHERIA; DOSE RESPONSE; DROWSINESS; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; ERYTHEMA; FEMALE; FEVER; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFANT; IRRITABILITY; MALE; NORMAL HUMAN; PAIN; PERTUSSIS; PRIORITY JOURNAL; TETANUS;

EID: 0038330666     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.1.3.277     Document Type: Article

References (21)

1. Yeoh EK. Hepatitis B virus infection in children. Vaccine 8, S29-S30 (1990).
2. Coates T, Wilson R, Patrick G, AndreF, Watson V. Hepatitis B vaccines: assessment of seroprotective efficacy of two recombinant DNA vaccines. Clin. Ther. 23, 392-403 (2001).
3. Pongpipat D, Suvatte V, Assateerawatts A. Vaccination against hepatitis B virus infection neonates. Helv. Paediatr. Acta 39, 231-236 (1984).
4. Win KM, Aye M, Han H-H et al. Comparison of separate and mixed administration of DTPw-HBV and Hib vaccines: immunogenicity and reactogenicity profiles. Int. J. Infect. Dis. 2, 79-84 (1997). Study in which a birth dose of hepatitis B was given with a DTPw-HB/Hib course.
5. Bravo L, Carlos J, Gatchalian S et al. The new DTPw-HBV-Hib combination vaccine can be used at the WHO schedule with a monovalent dose of hepatitis B vaccine at birth. Southeast Asian J. Trop. Med. Public Health 29, 772-778 (1998). Study in which a birth dose of hepatitis B was given with a DTPw-HB/Hib course.
6. World Health Organization. Informal consultation on quadrivalent diphtheria, tetanus, pertussis, hepatitis B vaccine. Final Report, WHO, Geneva, Switzerland, 1-12 (1992). WHO recommendations for use of DTPw-IB vaccines.
7. Poovorowan Y, Theamboonlers A, Sanpavat S et al. The immunogenicity and reactogenicity of combined tetravalent diphtheria, tetanus, pertussis and hepatitis B vaccine in infants. Viral Hep. Liver Dis. 526-529 (1994).
8. Usonis V, Bakasenas V, Taylor D, Vandepapelière P. Immunogenicity and reactogenicity of a combined DTPw-hepatitis B vaccine in Lithuanian infants. Eur. J. Pediatr. 155, 189-193 (1996).
9. Eskola J, Ward J, Dagan R et al. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 354, 2063-2068 (1999).
10. Diez-Delgado J, Dal-Ré R, Llorente M, Gonzélez A, López J. Hepatitis B component does not interfere with the immune response to diphtheria, tetanus and whole-cell Bordetella pertussis components of a quadrivalent (DTPw-HB) vaccine: a controlled trial in healthy infants. Vaccine 15, 1418-1422 (1997).
11. Ferreccio C, Ortis E, Astrosa L et al. A population based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, Chile. Ped-Infict. Dis. J. 9, 488-494 (1990).
12. Cochi SL, Broome CL, Hightower AW. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA 252, 521-529 (1985).
13. Sell SH. Long-term sequelae of bacterial meningitis in children. Pediatr. Infect. Dis. J. 2, 90-93 (1983).
14. Feldman WE, Ginsburg CM, McCRaken GH, Allen D, Ahmann P, Graham J, Graham L. Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis. J. Pediatr. 100, 209-212 (1982).
15. World Health Organization (WHO). Vaccines and Biologicals Annual Report, 1998. World Health Organization, Geneva, Switzerland (1999). WHO recommendations for infant antihepatitis B vaccination schedules.
16. Bassily S, Kotkat A, Gray G et al. Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates. Am J. Trop. Hyg. 53, 419-422 (1995).
17. Ferreocio C, Clemens J, Avendano A et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertusis vaccine at two, four and si xmonths of age-Pediatr. Infect. Dis. J. 10, 764-771 (1991).
18. Aristegui J, Garrote E, Gonzáez A, Arrate J-P, Perez A, Vandepapelière P. Immune response to a combined hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine. Vaccine 15, 7-9 (1997).
19. Ramkissoon A, Coovadia HM, Jugnundan P, Willems P, Clemens BR. A new combined DTP-HBV-Hib vaccine-strategy for incorporation of Hib vaccination into childhood immunisation programmes. S. Afr. Med J. 91, 864-869 (2001).
20. Santos JI, Martin AS, DeLeon T et al. DTPw-HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children. Vaccine 15, 1887-1893 (2002).
21. The International Task Force on Hepatitis B Immunization. Global Perspectives on Hepatitis Perspectives 4 (1) 1-8 (1993).